A cyclic enkephalin analog with high in vitro opiate activity

Area of Science:

• Medicinal Chemistry
• Neuroscience
• Peptide Chemistry

Background:

• Enkephalins are endogenous opioid peptides crucial for pain modulation.
• Understanding enkephalin conformation is key to developing potent analgesics.
• Linear enkephalins are rapidly degraded by enzymes, limiting their therapeutic potential.

Purpose of the Study:

• To synthesize and characterize a conformationally restricted analog of [Leu5]enkephalin.
• To evaluate the analog's potency, receptor binding affinity, and stability against enzymatic degradation.
• To investigate the role of conformational restriction in enkephalin activity and receptor interaction.

Main Methods:

• Synthesis of a cyclic enkephalin analog, H-Tyr-cyclo(-N gamma-D-A2bu-Gly-Phe-Leu-), via cyclization.
• Pharmacological evaluation using guinea pig ileum and rat brain receptor binding assays.
• Assessment of resistance to degradation by brain "enkephalinases".

Main Results:

• The cyclic D isomer, H-Tyr-cyclo(-N gamma-D-A2bu-Gly-Phe-Leu-), exhibited 17.5-fold higher potency in the guinea pig ileum assay and twofold higher potency in rat brain receptor binding compared to [Leu5]enkephalin.
• The L-isomer diastereomer showed significantly lower activity.
• The cyclic D isomer demonstrated superior stability against brain "enkephalinases" and higher activity than an open-chain analog.

Conclusions:

• Conformational restriction via cyclization significantly enhances enkephalin analog potency and stability.
• The synthesized cyclic analog provides a valuable tool for studying enkephalin-receptor interactions.
• This approach holds promise for developing novel, long-lasting analgesic agents.